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The cardiac conduction system (CCS) is composed of a group of myocardial tissues that
control and coordinate the heart. Alterations in the CCS – especially in the His–Purkinje
system, have been identified as a major cause of lethal arrhythmias. Unstable arrhythmias
secondary to channelopathies significantly increase the risk of sudden cardiac death (SCD).
SCD is a major contributor to mortality in industrialized countries, and most cases of SCD in
the young are related to inherited ion channel diseases. In this paper, we review a series of
studies with murine transgenic models that revealed that some arrhythmias are associated
with the CCS and may lead to SCD
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INTRODUCTION
Sudden cardiac death (SCD) occurs when an apparently healthy
person unexpected dies, which occurs within a very short time
interval – usually 1 h after symptom onset. Although sudden
death in infants, children, and young adults is relatively rare –
with an incidence of one to five cases per 100,000 population
per year, up to 7,000 asymptomatic children die every year in the
USA. In almost half of the cases no warning signs or symptoms
were detected. Although structural cardiovascular abnormalities
explain most cases of SCD in young people, the cause of death
remains unexplained after autopsy in 10–30% of cases (Kauferstein
et al., 2009). Cases of unexplained SCD in young people are mostly
due to inherited ion channel diseases such as long QT syndrome
(LQTS), short QT syndrome (SQTS), Brugada syndrome, and
catecholaminergic polymorphic ventricular tachycardia (CPVT)
(Krous et al., 2004; Basso et al., 2009).
The cardiac conduction system (CCS) generates and conducts
electrical signals (action potentials) throughout the heart to trig-
ger and coordinate the heartbeat. The electrical activity of the
heart behaves like the electrical activity of any other biologi-
cal tissue, and is ultimately dependent on the expression of ion
channels in the myocytes forming the CCS. Ion channel expres-
sion defines the characteristic action potentials generated by these
specialized myocytes, and is clearly different from that in the
working myocardium (Boyett, 2009). Interestingly, several recent
reports have pointed out that ion channel expression remodeling
within the different CCS components may be responsible for the
bradycardia and the increase in atrioventricular block with aging
(Muir et al., 2005, Abd Allah et al., 2007). There is growing evi-
dence that the different components of the CCS (e.g., Purkinje
fibers network) play a pivotal role in both the initiation and per-
petuation of several arrhythmias such as ventricular fibrillation
(VF; Nogami, 2001). In addition, recent mapping studies have
shown that Purkinje fibers can initiate VF in some patients with
pro-arrhythmogenic syndromes: Brugada syndrome, LQTS (Haïs-
saguerre et al., 2003). Despite the significant role of ion channels
in the electrical activity of CCS, their influence and contribution
to CCS dysfunctions are still poorly understood.
ELECTRICAL CONFIGURATION OF THE CARDIAC
CONDUCTION SYSTEM
The heart achieves coordinated contraction of atrial and ventric-
ular chambers thanks to the precise timing of firing of the CCS; it
is a specialized complex and heterogeneous network of cells that
initiate and allow propagation of action potentials through the
heart (Gourdie et al., 2003). The normal cardiac impulse in ver-
tebrates’ heart originates in the pacemaker cells of the sinoatrial
node (SAN) located in the right atrium (Anderson et al., 1983). The
impulse is then conducted through the atrium to the atrioventricu-
lar junction, where impulses are delayed through specialized slow
conducting cardiomyocytes in the atrioventricular node (AVN).
This delay is necessary to allow time for the atrial chambers to fully
contract and pump blood across AV valves before the occurrence
of ventricular contraction (Hatcher and Basson, 2009). After AVN
delay, the electrical signal is propagated to the ventricles along
bundles of specialized conduction tissue to the distal Purkinje
fibers, which ramify among the contractile myocardium. The tips
of the Purkinje fibers are electrically coupled to muscle cells and
the working myocytes are longitudinally connected via gap junc-
tions, thereby initiating a coordinated contraction of the ventricles
(Pennisi et al., 2002).
It is interesting to remark that the SA node is a complex and
irregular structure. There is regional heterogeneity in the SAN in
mammals in terms of cell morphology, pacemaker activity, action
potential configuration and conduction, ionic current densities
(INa ICa, L, Ito, Iks, If), gap junction protein expression (Cx40,
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Cx43, Cx45), and autonomic regulation (Hall et al., 2004; Herfst
et al., 2004). Moreover, although this bundle is located in the AV
junction area, its molecular phenotype shows most of the charac-
teristics of the working ventricular myocardium, displaying a high
conduction velocity compared to the slower conducting AV nodal
tissue (Franco and Icardo, 2001).
For instance, in ventricular and atrial myocytes and Purkinje
fibers, the upstroke of the action potential (phase 0) is rapid and
results from the activation of voltage-gated Na+ (Nav) channels.
However, phase 0 is markedly slower in the pacemaker cells of the
SAN and AVN suggesting that Nav channels do not play a relevant
role in depolarization (Baruscotti et al., 2005). These findings are
consistent with the heterogeneity found in Na+ channel expression
within the CCS (Domínguez et al., 2005, 2008).
Phase 0 of the action potential in Purkinje fibers and in atrial
and ventricular myocytes is followed by a transient repolarization
(phase 1), reflecting Nav channel inactivation and the activation
of the fast transient voltage-gated outward K+ current (Ito, f). This
transient repolarization or “notch,” which can be quite prominent
in Purkinje and ventricular cells, influences the height and dura-
tion of the action potential plateau (phase 2). Membrane depo-
larization also activates voltage-gated Ca2+ (Cav) currents; Ca2+
influx through L-type Cav channels during the phase 2 plateau
is the main trigger for excitation-contraction coupling in the
working myocardium. Thus, Ca2+ entering through L-type Cav
triggers a relatively larger release of Ca2+ from the sarcoplasmic
reticulum (SR) via intracellular Ca2+ release channels (ryanodine
receptors, RyRs). The increase in [Ca2+]i promotes cell contrac-
tion by Ca2+ binding to contractile proteins (Moosmang et al.,
2001). In SAN and AVN cells, activation of (L-type) Cav channels
also contributes to action potential generation, particularly in cells
expressing low levels of functional Nav channels (Moosmang et al.,
2001).
The driving force for K+ efflux is high during the plateau phase
of the action potential in the ventricular and atrial myocardium;
when Cav channels become inactive, outward K+ currents pre-
dominate resulting in repolarization (phase 3), and bringing mem-
brane voltage back to the resting potential. In contrast to Nav
and Cav currents, there are multiple types of voltage-gated K+
(Kv) currents, as well as non-voltage-gated, inwardly rectifying
K+ (Kir) currents that contribute to myocardial action poten-
tial repolarization: the greatest functional diversity is among Kv
channels.
At least two types of transient outward currents – Ito,
f and Ito, s – and several components of delayed rectifica-
tion – including IKr [IK(rapid)], IKs [IK(slow)], and IKur
[IK(ultrarapid), among others] – have been identified. How-
ever the timing and voltage-dependent properties of the dif-
ferent Kv currents identified in different regions of the heart
are remarkably similar. This suggests that the same (or very
similar) molecular entities contribute to the generation of
each of the Kv channels in different cells. Relative Kv channel
expression levels in cardiac cells vary according to the region
of the heart (i.e., atria, ventricles); this heterogeneity signifi-
cantly contributes to the observed regional differences in action
potential waveforms (Stieber et al., 2003; Aiba and Tomaselli,
2010).
CARDIAC CONDUCTION SYSTEM, ARRHYTHMOGENESIS,
AND SUDDEN CARDIAC DEATH: CONTRIBUTIONS FROM
MURINE MODELS
In the CCS, ion channels are specialized and differ from those in
the working myocardium, as they provide the electrical activity
required for its proper function. Although changes in the expres-
sion and/or configuration of ion channels and connections within
the conduction system may have fatal consequences – they can gen-
erate arrhythmogenic processes – the role of ion channels in CCS
dysfunction remodeling is not yet well understood. For instance, it
is noteworthy that in an aging heart, there are deleterious changes
in CCS remodeling that are a contributing factor to the relatively
high prevalence of cardiac arrhythmias, which increases the risk
of SCD in the aging population (Dobrzynski et al., 2007). Fur-
thermore, it is well known that athletes have a lower heart rate
than non-athletes, and sinoatrial node remodeling in athletes can
become pathological and result in a sick sinus syndrome (Baldes-
berger et al., 2008). Although there is growing evidence supporting
that molecular remodeling of electro-generating, propagating, and
coupling channels, as well as CCS structural remodeling may be
behind cardiac arrhythmias (Thomas et al., 2007), the mechanism
by which CCS remodeling takes place is still unknown.
With the development of transgenic animal technology, a grow-
ing number of experimental mouse/rat models have emerged.
However, as the cardiac electrophysiological characteristics of mice
are significantly different from those of humans, these models
have substantial limitations – e.g., the duration of cardiac action
potential is very short in mice; there is no plateau phase, and the
heart rate is extremely high (resting heart rate: 600 bpm) in mice.
Despite these differences, over the past 15 years, genetically engi-
neered mouse models have been developed to elucidate the role of
different ion channels in arrhythmogenic pathologies. The results
obtained suggest that CCS components play a major role in the
generation of cardiac arrhythmias. In this paper, we describe the
main mouse models with ion channel alterations in which a CCS
dysfunction leads to an arrhythmogenic substrate (Table 1).
MOUSE MODELS OF ION CHANNELS REMODELING LINKED
TO NODE TISSUE DYSFUNCTION
A number of mouse models have been developed to elucidate
the role of different ion channels in node tissue and in the gen-
eration of arrhythmias. For instance, different mouse transgenic
models have been developed with the aim of identifying the rela-
tionship between Hcn channel alterations and pacemaker activity.
The homozygous embryo mice lacking the exon 4 of the Hcn4
gene – which encodes ion channel pore and transmembrane seg-
ment six – died in the uterus, thus indicating that Hcn4 is essential
for the normal development of the heart (Stieber et al., 2003).
In contrast, the role of If in adult mice is controversial. As Hcn4
knockout mice fail to develop a normal heart, it has not been until
recently that we have elucidated whether If has the same prominent
role in adult as in embryonic mice.
Accordingly, Herrmann et al. (2007) developed an adult mouse
lacking Hcn4 channels in a temporally controlled manner. Dele-
tion of Hcn4 in adult mice eliminated most of sinoatrial If and
resulted in a cardiac arrhythmia characterized by recurrent sinus
pauses. However, these mutants showed no impairment in heart
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Table 1 | Mouse transgenic models with ion channel deficiency and CCS dysfunction.
Mouse model Ion channel deficiency/location Arrhythmogenic phenotype
Hcn4−/− mice (Stieber et al., 2003) Hcn4/systemic Died in utero
Hcn4-inducible-knockout mice (Herrmann et al., 2007) Hcn4/whole heart Recurrent sinus pauses
Hcn4-KiT mice (Hoesl et al., 2008) Hcn4/CCS Normal cardiac rhythm
ciHcn4-KO (Baruscotti et al., 2011) Hcn4/whole heart Severe bradycardia and AV block
Scn5a+/− mice (Hao et al., 2011; Martin et al., 2011) Nav1.5/systemic Reduced sinoatrial node automaticity/polymorphic
ventricular tachycardia
R176Q/+ knock-in mice (Mathur et al., 2009) Ryr2 mutation/systemic Sudden cardiac death
RyR(R4496C) mice (Cerrone et al., 2005, 2007) Ryr2 mutation/systemic CPVT/DAD activity in Purkinje fibers
rate acceleration during sympathetic stimulation, thus revealing
that, in adult mice,Hcn4 does not appear to be the only mechanism
involved in the adrenergic stimulation of sinus activity.
Moreover, conduction system-specific deletion of Hcn4 chan-
nels using the KiT transgene did not result in bradycardia (Hoesl
et al., 2008). This supports the notion that Hcn4 channels mainly
provide the depolarizing currents necessary to counterbalance an
increase in repolarizing currents in the CCS. On the contrary, in
an inducible and cardiac-specific Hcn4 knockout (ciHcn4-KO)
mouse model, ablation of Hcn4 consistently led to the progressive
development of severe bradycardia (∼50% reduction of original
rate) and AV block, eventually leading to heart arrest and death in
about 5 days. This outcome suggests that cardiac Hcn4 channels
are essential for normal heart impulse generation and conduction
in adult mice; in addition, these results support the notion that
dysfunctional Hcn4 channels can be a direct cause of rhythm dis-
orders, which lead to sudden death events (Baruscotti et al., 2011).
These contradictory results might be partially due to the nature
of the mouse models used in these studies, as they were designed
to lack a Hcn channel within the whole heart, and/or within both
the SAN and AVN (Table 1). The development of Cre deleter
mouse lines – which can render sinoatrial-specific Hcn channel
deletion – will help to better understand the role of Hcn channels
in pacemaker activity.
Knockout mouse models for other key cardiac ion channels
are also useful tools for evaluating how a misexpression of spe-
cific ion channels can generate an arrhythmogenic substrate. Thus,
Nav1.5 deficiency in heterozygous Scn5a knockout [Scn5a(+/−)]
mice resulted in reduced SAN automaticity, which suggests that
the loss of expression/function of sodium currents can severely
impair action potentials in pacemaker cells. Moreover, downregu-
lation of a wide range of other ion channels and related transcripts
in Scn5a(+/−) mice suggest that impaired Scn5a expression may
lead to significant electric remodeling in the sinus node (Hao et al.,
2011).
In addition, the contribution of transcription factors to proper
CCS embryonic development is being widely explored. Previ-
ous studies have described that the T-box transcription factor
Tbx3 is predominantly expressed in developing and mature pace-
makers [SAN and AV canal (AVC) and node], as well as in the
AVB and branches. Tbx3 is sufficient to induce the formation of
ectopic pacemakers in the atrial myocardium during its develop-
ment (Hoogaars et al., 2004, 2007). These data suggest a role for
Tbx3 in mammalian cardiac development and CCS function. More
recently, the generation of a unique series of Tbx3 hypomorphic
and conditional mouse mutants (Frank et al., 2011) revealed that
the development of the CCS structure and function is extremely
sensitive to Tbx3, to the extent that a decrease in Tbx3 below a crit-
ical level causes lethal embryonic arrhythmias; these arrhythmias
are accompanied by disrupted expression of multiple ion channels
such as voltage-gated sodium channels (Scn7a) and Connexin-
30.2. Furthermore, surviving Tbx3 mutants are at an increased risk
for sudden death, thus suggesting that TBX3 may be a candidate
gene for human arrhythmia syndromes.
MOUSE MODELS OF ION CHANNEL REMODELING LINKED TO
PURKINJE SYSTEM DYSFUNCTION
Catecholaminergic polymorphic ventricular tachycardia is an
inherited disease leading to arrhythmias and SCD. The autoso-
mal dominant form has been associated with ryanodine recep-
tor gene (RyR2) mutations, leading to increased spontaneous
Ca2+ release from the SR (Priori et al., 2001). Mice heterozygous
for the R4496C mutation (RyR2/RyR2R4496C) recapitulate the
human phenotype of CPVT by developing ventricular tachycardia
and/or VF under adrenergic stimulation (Cerrone et al., 2005).
More recently, epicardial and endocardial optical mapping analy-
ses have demonstrated that arrhythmias in RyR2/RyR2R4496C
mice are mediated by delayed afterdepolarization (DAD)-induced
triggered activity occurring in Purkinje fibers; this reveals that
the His–Purkinje system is an important source of focal arrhyth-
mias in CPVT (Cerrone et al., 2007). Some authors have sug-
gested that RYR2 mutations may cause “arrhythmogenic right
ventricular dysplasia type 2” (ARVD2), a condition character-
ized by fibro-fatty degeneration of the right ventricle and by
the presence of ventricular arrhythmias. The generation of a
knock-in mouse model with the R176Q mutation (a human
Ryr2 mutation previously identified in a 15-year-old male with
ARVD2) led us to better understand the relationship between
Ryr2 mutations and ARVD2. During the experiment, R176Q/+
knock-in mice displayed an increased incidence of sudden unex-
pected death during the first weeks of life, and electrophysiolog-
ical recordings displayed cardiac arrhythmias in R176Q/+ mice
associated with SCD (Mathur et al., 2009). In another study,
Kang et al. (2010) crossed RyR2R4496C/+ CPVT mutant mice
with Cntn2-EGFP BAC transgenic mice (which express a fluo-
rescent reporter gene in cells of the CCS). Interestingly, Kang’s
study revealed that the RyR2(R4496C/+) Purkinje cells display
a greater propensity to develop abnormalities in intracellular
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Ca2+ handling than ventricular myocytes. This proarrhythmic
behavior was enhanced by disease-causing mutations in the RyR2
Ca2+ release channel and greatly exacerbated by catecholaminergic
stimulation, with the development of arrhythmogenic triggered
beats.
Finally, very recent experiments carried out using the Scn5a+/−
mouse model – which has been shown to closely reproduce many
of the key features of Brugada syndrome (a genetic channelopathy
strongly linked to SCD) in humans – have revealed that Scn5a+/−
mice display lines of conduction block across the RV resulting
from premature ventricular beats led to the formation of reen-
trant circuits and polymorphic ventricular tachycardia (Martin
et al., 2011). Some authors have reported that the Purkinje system
plays a major role in the development of VF in patients with LQTS
and Brugada syndrome (Haïssaguerre et al., 2003). Consequently,
the results obtained suggest that the Purkinje system might
play a significant role in the outset of the electrophysiological
abnormalities found in Scn5+/−mice.
CONCLUDING REMARKS
There is growing evidence that ion channel remodeling within the
CCS may play a crucial role in the generation of cardiac arrhyth-
mias associated with SCD. A number of mouse transgenic models
have been developed to analyze the role of the different ion chan-
nels in the development of specific arrhythmias. Studies with these
animal models have revealed that the arrhythmias associated with
changes in ion channel expression/function within the heart are
mainly caused by an impaired CCS component. Therefore, an
understanding of the role of ion channels within the CCS will lead
to the development of new treatments for cardiac diseases such as
sick sinus syndrome, AV block, and tachycardia which origin is in
the CCS.
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